CoChat

From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights

De Minicis, Samuele, Day, Chris, Svegliati-Baroni, Gianluca · 2013 · Current Pharmaceutical Design
Cited by 78

The DOI matches its Crossref record.

Abstract

NAFLD is the most common liver disease worldwide but it is the potential evolution to cirrhosis and hepatocellular carcinoma (HCC) that makes NAFLD of such clinical importance. The current work provides an overview of the main mechanims and potential therapeutical insights involved in NAFLD, NASH, fibrosis and HCC progression. Keywords: NAFLD, NASH, fibrosis, microbiota, bacterial translocation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1381612811319290006

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 78

Metadata

Authors
De Minicis, S., Day, C., & Svegliati-Baroni, G.
Venue
Current Pharmaceutical Design
Published
2013-07-01
Volume
19
Issue
29
Pages
5239-5249
ISSN
1381-6128 (ISSN-L)
OpenAlex
W2090674703
Cited by
78
References
0
FWCI
4.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. https://app.cochat.ai/papers/10.2174/1381612811319290006
The paper
De Minicis, S., Day, C., & Svegliati-Baroni, G. (2013). From NAFLD to NASH and HCC: Pathogenetic Mechanisms and Therapeutic Insights. Current Pharmaceutical Design. https://doi.org/10.2174/1381612811319290006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.